Summary
Amgen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Amgen, Inc. (Amgen) discovers, develops, manufactures, and distributes innovative medicines. It specializes in therapeutic areas including oncology, cardiovascular diseases, osteoporosis, inflammatory conditions, and rare diseases. Amgen markets its products through pharmaceutical wholesale distributors and direct-to-consumer channels to healthcare providers such as physicians, clinics, hospitals, and pharmacies. Its product portfolio includes brands such as Actimmune, Blincyto, Epogen, Kanjinti, Mvas, Parsabiv, and Tepezza. Amgen serves markets across the Asia Pacific, the Americas, Europe, the Middle East, and Africa. It operates manufacturing facilities in the US, Puerto Rico, Ireland, the Netherlands, and Singapore. Amgen is headquartered in Thousand Oaks, California, the US.
Scope
- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Amgen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amgen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Amgen, Inc.'s business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Amgen, Inc.: Company Overview
Amgen, Inc.: Overview and Key Facts
Amgen, Inc.: Overview
Amgen, Inc.: Key Facts
Amgen, Inc.: Key Employees
Amgen, Inc.: Key Employee Biographies
Amgen, Inc.: Major Products and Services
Amgen, Inc.: Management Statement
Amgen, Inc.: Locations and Subsidiaries
Amgen, Inc.: Key Competitors
Amgen, Inc.: Company Analysis
Amgen, Inc.: Business Description
Amgen, Inc.: SWOT Analysis
Amgen, Inc.: SWOT Overview
Amgen, Inc.: Strengths
Amgen, Inc.: Weaknesses
Amgen, Inc.: Opportunities
Amgen, Inc.: Threats
Amgen, Inc.: Corporate Financial Deals Activity
Amgen, Inc.: Financial Deals Overview
Amgen, Inc.: Targets and Partners
Amgen, Inc.: Top Deals 2021 - 2025YTD*
Amgen, Inc.: Advisors
Amgen, Inc.: Top Legal Advisors
Amgen, Inc.: Top Financial Advisors
Amgen, Inc.: Mergers and Acquisitions
Amgen, Inc.: Corporate Venturing
Amgen, Inc.: Capital Raising
Amgen, Inc.: Partnership
Amgen, Inc.: Divestments
Amgen, Inc.: Recent Developments
Amgen, Inc.: News and Events Summary
Amgen, Inc.: Contracts
Amgen, Inc.: Corporate Governance
Amgen, Inc.: Financial Performance
Amgen, Inc.: Market Developments
Amgen, Inc.: Regulatory and Legal Events
Amgen, Inc.: Research & Development
Amgen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Amgen, Inc.: Key Facts
Table 2: Amgen, Inc.: Key Employees
Table 3: Amgen, Inc.: Locations and Subsidiaries
Table 4: Amgen, Inc.: Key Competitors
Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Amgen, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 7: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Amgen, Inc.: Targets and Partners
Table 9: Amgen, Inc.: Top Deals 2021 - 2025YTD*
Table 10: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Amgen, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
Table 13: Amgen, Inc.: M&A Activity by Geography (2021 - YTD*2025)
Table 14: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 15: Amgen, Inc.: Corporate Venturing by Geography (2021 - YTD*2025)
Table 16: Amgen, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Table 17: Amgen, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
Table 18: Amgen, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 19: Amgen, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 20: Amgen, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 21: Amgen, Inc.: Divestments by Geography (2021 - YTD*2025)
Table 22: Amgen, Inc.: News and Events Summary
Table 23: Amgen, Inc.: Contracts
Table 24: Amgen, Inc.: Corporate Governance
Table 25: Amgen, Inc.: Financial Performance
Table 26: Amgen, Inc.: Market Developments
Table 27: Amgen, Inc.: Regulatory and Legal Events
Table 28: Amgen, Inc.: Research & Development
Table 29: Amgen, Inc.: Strategy and Operations
List of Figures
Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Amgen, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Amgen, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 5: Amgen, Inc.: M&A Activity by Geography (2021 - YTD*2025)
Figure 6: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Figure 7: Amgen, Inc.: Corporate Venturing by Geography (2021 - YTD*2025)
Figure 8: Amgen, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Figure 9: Amgen, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
Figure 10: Amgen, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 11: Amgen, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
Figure 12: Amgen, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
Figure 13: Amgen, Inc.: Divestments by Geography (2021 - YTD*2025)
